Profiles

Guna Karupiah

UTAS Home Associate Professor Guna Karupiah

Guna Karupiah

Associate Professor in Biomedicine

Room 241 , Hobart CBD Campuses

+61 6226 2658 (phone)

Guna.Karupiah@utas.edu.au

If you, or someone you love, seek treatment for influenza or viral pneumonia more than 48 hours after the onset of symptoms, no specific cure is currently available. Sadly, this reality will mean death for many previously healthy people, as it did for many Australians during the 2017 flu season. But there may be hope.

Extending the reach of antivirals and treatment for viral pneumonia

Dr Guna Karupiah, Associate Professor of Biomedicine in the UTAS School of Medicine, is an expert in immunology and virology. He has devoted his career to researching the immune response to pox and influenza virus infections. In a major breakthrough, Dr Karupiah’s latest research has revealed that antivirals will effectively treat influenza pneumonia long after 48 hours post-onset of symptoms if they are used in combination with anti-inflammatory drugs – at least it has, to date, with mice.

‘One logical conclusion behind these findings is that our immune response is actually preventing these antivirals from working,’ Dr Karupiah said. ‘Inflammation is an important part of the body’s response against any viral infection, and pneumonia is excessive inflammation of the lung, produced when the immune system goes out of control. If it’s a new strain of virus, which our body has not been exposed to previously, the immune system overreacts to control the infection and inadvertently causes a lot of damage through inflammation. That is where the anti-inflammatories can be effective.

‘We will need to do more animal experiments to ensure that our findings are robust and reproducible. The next step would be to get funding for clinical trials in humans. That’s a while away, but it’s a big finding because we’ve been able to demonstrate it in two different viral models. If we reduce inflammation long after the onset of symptoms, we can actually make the antivirals work.’

Drawing on previous research

Dr Karupiah has extensive experience in working with mousepox, an excellent small animal surrogate model for smallpox. The mousepox model has been crucial to understanding why the smallpox virus killed up to 40 per cent of infected individuals. The mousepox virus is a mouse pathogen and has co-evolved with mice, just as the smallpox virus has co-evolved with humans. Both viruses have close similarities in terms of respiratory infection, disease and pathogenesis and are also in the same virus family.

Based on the success of the mousepox model, which provided an insight into the pathogenesis of viral infections, Dr Karupiah applied some of the findings to his research into influenza pneumonia. As had been shown by others previously, the antiviral drugs didn’t work in mice in the influenza model post-onset of symptoms, just like they don’t in humans. But when anti-inflammatory drugs were used in combination with the antivirals, the mice could be treated and fully recovered. The anti-inflammatory drugs that were used are already available for use in humans.

‘I decided to work on the antivirals because there is a huge gap in what is needed,’ Dr Karupiah said. ‘There is a lot of research in laboratories around the world in making vaccines more effective, but there’s not much going on in terms of how we can treat an individual who is already infected and presents to a doctor long after the onset of symptoms.

‘So there is a lack of treatment for people who are infected with influenza and develop pneumonia, but this problem is not unique to influenza. We’ve done this research with the mousepox model as well. We also know that, for example, the chickenpox virus can be reactivated as shingles in some adults, but the antivirals don’t work if those individuals present to a doctor 48 to 72 hours post-onset of symptoms. So my thinking is that what we’ve been able to show with the pox virus and the influenza virus models is probably going to be applicable to other viral infections as well.’

Since joining UTAS in 2016, Dr Karupiah has also been teaching in the School of Medicine. Previously he worked as a postdoctoral fellow at the National Institutes of Health (NIH, USA) at the Laboratory of Viral Diseases and then the Laboratory of Immunopathology, before returning to Australia to lead successful labs at the University of Sydney and the Australian National University.

Associate Professor Guna Karupiah (Guna) is internationally regarded as an expert on immunity to pox and other generalized viral infections. The significance and impact of his research is evidenced by the highly competitive fellowships he has held, invitations to national and international conferences and workshops, invitations to expert or advisory panels, professional activities and peer review involvement.

His current interests and research projects are immunological memory (humoral immunity), viral infection induced immunopathology (viral pneumonia, cytokine storm) and viral immune evasion.

Biography

Guna trained as a microbiologist (BSc Hons) and then specialised in medical virology and epidemiology (MSc) at the University of Malaya. After completing his PhD in viral immunology at the John Curtin School of Medical Research (JCSMR), Australian National University (ANU), he worked as a postdoctoral fellow at the National Institutes of Health (NIH, USA) at the Laboratory of Viral Diseases and then the Laboratory of Immunopathology. After returning to Australia, has headed successful labs at the University of Sydney and the ANU. He joined the School of Medicine, University of Tasmania in January 2016.

Career summary

Qualifications

PhD

Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2

Australian National University

Australia

1990

MSc

Rapid diagnosis and epidemiology of dengue virus infections in Malaysia

University of Malaya

Malaysia

1986

BSc (Hons)

A biochemical and serological survey of the dengue virus epidemic in Malaysia

University of Malaya

Malaysia

1983

Senior Fellow of the Higher Education Academy, UK

 

Australian National University

Australia

2014

Languages (other than English)

Malay, Tamil, Indonesian

Memberships

Professional practice

  • American Society for Microbiology
  • American Association of Immunologists
  • American Society for Virology
  • Australasian Society for Immunology

Administrative expertise

Guna has managed a large National Institutes of Health funded research program on high-throughput screens of mice to reveal genes that confer resistance and susceptibility to class A pathogens (Poxvirus).

Teaching

Viral Immunology; Immunology; Virology; Immunopathology; Viral pneumonia; Vaccines and vaccination strategies; Immune evasion by viruses; Poxviruses; Influenza A virus; Cell-mediated immunity; Antibody responses; Cytokines; Leukocyte subsets.

Teaching expertise

  • Viral Immunology, Immunology, Virology
  • Design of 3rd year BSc Molecular Immunology course at the Australian National University

Teaching responsibility

View more on AssocProf Guna Karupiah in WARP

Expertise

  • Novel treatment of viral pneumonia
  • New strategies for viral vaccine design
  • Understanding how the immune system works in health and disease
  • Poxvirus pathogenesis
  • Smallpox and Mousepox
  • Immune Evasion

Research Themes

Guna’s research aligns with the University’s research theme of Better Health.The long-standing focus of his research has been to understand the mechanics of an optimal immune response to viral infection with the ultimate goal of developing new efficacious vaccines and ways of intervening in the disease process if infection takes hold. As the host immune response has co-evolved with pathogens, meaningful investigations require appropriate virus-host models and this principle has guided his work. He strongly believes that understanding immune mechanisms at the molecular level through basic research using animal models is a key for translation into innovative and usable outcomes for treating infectious diseases in humans.

Collaboration

1. Modulation of the immune response by virus-encoded cytokine homologs

  • Dr. Geeta Chaudhri, Australian National University
  • Professor Mark Buller, St. Louis University, St Louis, USA
  • Professor Antonio Alcami, Centro de Biología Molecular Severo Ochoa, Madrid, Spain

2. Induction of long-lived antiviral humoral immunity

  • Dr. Geeta Chaudhri, Australian National University
  • Dr. Timothy Newsome, School of Molecular Bioscience, University of Sydney
  • Professor Robert Brink, Garvan Institute for Medical Research, Sydney

3. Systems approach to immunity and inflammation

  • Professor Richard Ulevitch, Scripps Research Institute, La Jolla, USA
  • Professor Bruce Beutler, University of Texas Southwestern, USA
  • Professor Alan Aderem, Seattle Biomed, Seattle, USA
  • Professor Garry Nolan, Stanford University, California, USA
  • Professor Christopher Goodnow, Garvan Institute for Medical Research, Sydney

4. Pathophysiological significance of reverse signalling through membrane TNF

  • Dr. Geeta Chaudhri, Australian National University
  • Professor Antonio Alcami, Centro de Biología Molecular Severo Ochoa, Madrid, Spain

5. Viral and host schlafen genes in inflammation and immunity to virus infection

  • Professor Bruce Beutler, University of Texas Southwestern, USA
  • Professor Antonio Alcami, Centro de Biología Molecular Severo Ochoa, Madrid, Spain

Awards

  • NHMRC Senior Research Fellowship
  • Howard Hughes Medical Institute International Research Fellowship, USA
  • University of Sydney Medical Foundation Fellowship
  • John E. Fogarty Research Fellowship, National Institutes of Health, USA

Current projects

1. Why do live viral vaccines induce life-long, protective antibody responses?

Vaccination with live viral vaccines provides life-long immunity. In contrast, inactivated vaccines induce short-lived antibody responses. In this project, the molecular and cellular basis for these differences will be investigated, utilizing novel recombinant viruses as well as transgenic, mutant and wild type mice to address some fundamental questions in immunology. It will involve techniques in immunology, virology, molecular biology and proteomics. This project is relevant for developing improved vaccination strategies.

2. A novel approach to treatment of viral pneumonia

Viral infection-induced pneumonia is a consequence of an over-exuberant immune response associated with dysregulated inflammatory cytokine production. There are no specific treatments available for viral pneumonia. We have developed a novel regime for treatment of viral pneumonia and preliminary results indicate that a combination of an antiviral plus a second compound is very effective in significantly reducing viral load, lung pathology and increasing survival even if treatment is started after onset of symptoms. This project will investigate the mechanisms through which the combination therapy ameliorates pneumonia and will assess the effectiveness of additional compounds. The project will utilize various strains of influenza A virus, wild type, gene knockout and gene knockin mice and will involving immunology, virology, molecular biology, cell signaling and histopathology techniques.

3. Mechanisms of protection of the host by virus-encoded TNF receptor homolog

Tumor necrosis factor (TNF) is a type II transmembrane cytokine (mTNF) expressed on activated cells and cleaved by a metalloproteinase to yield the soluble form (sTNF). Poxviruses encode TNF receptor (vTNFR) homologs of the extracellular domain of mammalian TNFR, which can potentially subvert the host immune response. Ectromelia virus (ECTV), an orthopoxvirus closely related to variola virus (smallpox virus) and a natural mouse pathogen, encodes a vTNFR that is secreted. This project will investigate how vTNFR modulates the host response using genetically engineered mutant viruses and gene knockout/knockin mice. It will use immunology, virology, molecular biology and cell signaling techniques. This project is highly relevant to anti-TNF therapies currently used to treat chronic inflammatory diseases.

4. Mouse and viral schlafen genes in infection and immunity

Some members of the family of human and mouse schlafen (Slfn) genes are involved in the activation and differentiation of immune cells. The mechanisms through which the Slfn proteins mediate their activities or the proteins they interact with are not known. Variola virus (VARV, the causative agent of smallpox in humans) and ectromelia virus (ECTV), a mouse-specific virus causing a smallpox-like disease (mousepox) are both poxviruses, which encode homologs of the mammalian schlafen genes. This project will investigate the mechanisms through which viral schlafen gene expression modulates the host immune response. It will utilize novel, genetically engineered mutant viruses and gene knockout/knockin mice involving immunology, virology, molecular biology and cell signaling techniques.

Fields of Research

  • Innate immunity (320407)
  • Cellular immunology (320404)
  • Medical virology (320705)
  • Immunology (320499)
  • Virology (310706)
  • Humoural immunology and immunochemistry (320405)
  • Medical biotechnology diagnostics (incl. biosensors) (320602)
  • Cellular interactions (incl. adhesion, matrix, cell wall) (310105)
  • Cell metabolism (310103)
  • Medical bacteriology (320701)
  • Bacteriology (310701)
  • Respiratory diseases (320103)
  • Molecular evolution (310510)
  • Transplantation immunology (320408)
  • Autoimmunity (320403)
  • Tumour immunology (320409)

Research Objectives

  • Prevention of human diseases and conditions (200104)
  • Clinical health (200199)
  • Efficacy of medications (200102)
  • Treatment of human diseases and conditions (200105)
  • Expanding knowledge in the health sciences (280112)

Publications

Guna Karupiah has 64 publications, and has edited a book on Gamma Interferon in Antiviral Defense. His published papers appear in world class refereed journals that have an average impact factor of 7.2, placing them in the top 3.3% of international journals in the 2015 SCI Journal Citation Reports. His publications have been cited over 3,800 times as reported by the ISI Science Citation Index. In the last 5 years, his published papers have appeared in world class refereed journals that are in the top 2.5 percentile of international journals.

Total publications

79

Journal Article

(66 outputs)
YearCitationAltmetrics
2020Al Rumaih Z, Kels MJT, Ng E, Pandey P, Pontejo SM, et al., 'Poxvirus-encoded TNF receptor homolog dampens inflammation and protects from uncontrolled lung pathology during respiratory infection', National Academy of Sciences of The United States of America. Proceedings, 117, (43) pp. 26885-26894. ISSN 0027-8424 (2020) [Refereed Article]

DOI: 10.1073/pnas.2004688117 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Pandey P

Tweet

2020Gowripalan A, Abbott CR, McKenzie C, Chan WS, Karupiah G, et al., 'Cell-to-cell spread of vaccinia virus is promoted by TGF-β-independent Smad4 signalling', Cellular Microbiology Online, 22, (8) pp. 1-18. ISSN 1462-5822 (2020) [Refereed Article]

DOI: 10.1111/cmi.13206 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2020KC R, Hyland IK, Smith JA, Shukla SD, Hansbro PM, et al., 'Cow dung biomass smoke exposure increases adherence of respiratory pathogen nontypeable Haemophilus infuenzae to human bronchial epithelial cells', Exposure and Health ISSN 2451-9766 (2020) [Refereed Article]

DOI: 10.1007/s12403-020-00351-y [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: KC R; Hyland IK; Smith JA; Zosky GR; O'Toole RF

Tweet

2020KC R, Leong KWC, Harkness NM, Lachowicz J, Gautam SJ, et al., 'Whole-genome analyses reveal gene content differences between nontypeable Haemophilus influenzae isolates from chronic obstructive pulmonary disease compared to other clinical phenotypes', Microbial Genomics, 6, (8) pp. 1-12. ISSN 2057-5858 (2020) [Refereed Article]

DOI: 10.1099/mgen.0.000405 [eCite] [Details]

Citations: Web of Science - 2

Co-authors: KC R; Gautam SJ

Tweet

2020KC R, Leong KWC, McEwan B, Lachowicz J, Harkness NM, et al., 'Draft genome sequence of an isolate of nontypeable Haemophilus influenzae from an acute exacerbation of chronic obstructive pulmonary disease in Tasmania', Microbiology Resource Announcements, 9, (19) pp. 1-2. ISSN 2576-098X (2020) [Refereed Article]

DOI: 10.1128/MRA.00375-20 [eCite] [Details]

Citations: Scopus - 1

Co-authors: KC R; O'Toole RF

Tweet

2020Tuazon Kels MJ, Ng E, Al Rumaih Z, Pandey P, Ruuls SR, et al., 'TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection', Proceedings of the National Academy of Sciences of the United States of America, 117, (27) pp. 15935-15946. ISSN 0027-8424 (2020) [Refereed Article]

DOI: 10.1073/pnas.2004615117 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Pandey P; Korner H

Tweet

2019Eldi P, Chaudhri G, Nutt SL, Newsome TP, Karupiah G, 'Viral replicative capacity, antigen availability via hematogenous spread, and high TFH:TFR ratios drive induction of potent neutralizing antibody responses', Journal of Virology, 93, (6) pp. 1-17. ISSN 0022-538X (2019) [Refereed Article]

DOI: 10.1128/JVI.01795-18 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2019Zammit NW, Siggs OM, Gray PE, Horikawa K, Langley DB, et al., 'Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity', Nature Immunology, 20, (10) pp. 1299-1310. ISSN 1529-2908 (2019) [Refereed Article]

DOI: 10.1038/s41590-019-0492-0 [eCite] [Details]

Citations: Scopus - 17Web of Science - 18

Tweet

2018Chaudhri G, Kaladimou G, Pandey P, Karupiah G, 'Propagation and Purification of Ectromelia Virus', Current Protocols in Microbiology, 51, (1) ISSN 1934-8525 (2018) [Refereed Article]

DOI: 10.1002/cpmc.65 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Pandey P

Tweet

2018Duncan ML, Horsington J, Eldi P, Al Rumaih Z, Karupiah G, et al., 'Loss of actin-based motility impairs ectromelia virus release in vitro but is not critical to spread in vivo', Viruses, 10, (3) Article 11. ISSN 1999-4915 (2018) [Refereed Article]

DOI: 10.3390/v10030111 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2018Zanker D, Pang K, Oveissi S, Lu C, Faou P, et al., 'LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins', Immunology and Cell Biology, 96, (9) pp. 981-993. ISSN 0818-9641 (2018) [Refereed Article]

DOI: 10.1111/imcb.12163 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Tweet

2015Chaudhri G, Tahiliani V, Eldi P, Karupiah G, 'Vaccine-Induced Protection against Orthopoxvirus Infection Is Mediated through the Combined Functions of CD4 T Cell-Dependent Antibody and CD8 T Cell Responses', Journal of Virology, 89, (3) pp. 1889-1899. ISSN 1098-5514 (2015) [Refereed Article]

DOI: 10.1128/JVI.02572-14 [eCite] [Details]

Citations: Scopus - 12Web of Science - 10

Tweet

2015Sakala IG, Chaudhri G, Scalzo AA, Eldi P, Newsome TP, et al., 'Evidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naive Mice', PLoS pathogens, 11, (12) pp. 1-26. ISSN 1553-7366 (2015) [Refereed Article]

DOI: 10.1371/journal.ppat.1005342 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Tweet

2015Sakala IG, Chaudri G, Eldi P, Buller RM, Karupiah G, 'Deficiency in Th2 Cytokine Responses Exacerbate Orthopoxvirus Infection', PloS one, 10, (3) Article e0118685. ISSN 1932-6203 (2015) [Refereed Article]

DOI: 10.1371/journal.pone.0118685 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Tweet

2014Andoniou CE, Sutton VR, Wikstrom ME, Fleming P, Thia KY, et al., 'A Natural Genetic Variant of Granzyme B Confers Lethality to a Common Viral Infection', PLoS pathogens, 10, (12) pp. 1-13. ISSN 1553-7366 (2014) [Refereed Article]

DOI: 10.1371/journal.ppat.1004526 [eCite] [Details]

Citations: Scopus - 10Web of Science - 9

Tweet

2013Gatto D, Wood K, Caminschi I, Murphy-Durland D, Schofield P, et al., 'The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells', Nature Immunology, 14, (5) pp. 446-453. ISSN 1529-2908 (2013) [Refereed Article]

DOI: 10.1038/ni.2555 [eCite] [Details]

Citations: Scopus - 103Web of Science - 101

Tweet

2013Horsington J, Lynn H, Turnbull L, Cheng D, Braet F, et al., 'A36-dependent Actin Filament Nucleation Promotes Release of Vaccinia Virus', PLoS pathogens, 9, (3) pp. 1-15. ISSN 1553-7366 (2013) [Refereed Article]

DOI: 10.1371/journal.ppat.1003239 [eCite] [Details]

Citations: Scopus - 29Web of Science - 24

Tweet

2013Tahiliani V, Chaudri G, Eldi P, Karupiah G, 'The orchestrated functions of innate leukocytes and T cell subsets contribute to humoral immunity, virus control, and recovery from secondary poxvirus challenge', Journal of Virology, 87, (7) pp. 3852-61. ISSN 0022-538X (2013) [Refereed Article]

DOI: 10.1128/JVI.03038-12 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2012Chang PP, Lee SK, Hu X, Davey G, Duan G, et al., 'Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells', Journal of Immunology, 189, (2) pp. 701-10. ISSN 0022-1767 (2012) [Refereed Article]

DOI: 10.4049/jimmunol.1102432 [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Tweet

2012Lynn H, Horsington J, Ter LK, Han S, Chew YL, et al., 'Loss of Cytoskeletal Transport during Egress Critically Attenuates Ectromelia Virus Infection In Vivo', Journal of Virology (Online), 86, (13) pp. 7427-7443. ISSN 1098-5514 (2012) [Refereed Article]

DOI: 10.1128/JVI.06636-11 [eCite] [Details]

Citations: Scopus - 18Web of Science - 18

Tweet

2011Haque A, Best SE, Unosson K, Amante FH, de Labastida F, et al., 'Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria', Journal of Immunology, 186, (11) pp. 6148-56. ISSN 0022-1767 (2011) [Refereed Article]

DOI: 10.4049/jimmunol.1003955 [eCite] [Details]

Citations: Scopus - 116Web of Science - 117

Tweet

2010O'Gorman WE, Sampath P, Simonds EF, Sikorski R, O'Malley M, et al., 'Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses', Cell Host and Microbe, 8, (2) pp. 174-185. ISSN 1931-3128 (2010) [Refereed Article]

DOI: 10.1016/j.chom.2010.07.008 [eCite] [Details]

Citations: Scopus - 21Web of Science - 21

Tweet

2010Panchanathan V, Chaudhri G, Karupiah G, 'Antiviral protection following immunization correlates with humoral but not cell-mediated immunity', Immunology and Cell Biology, 88, (4) pp. 461-467. ISSN 0818-9641 (2010) [Refereed Article]

DOI: 10.1038/icb.2009.110 [eCite] [Details]

Citations: Scopus - 22Web of Science - 20

Tweet

2009Chaudhri G, Quah BJ, Wang Y, Tan AHY, Zhou J, et al., 'T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control', National Academy of Sciences of The United States of America. Proceedings, 106, (35) pp. 14984-9. ISSN 0027-8424 (2009) [Refereed Article]

DOI: 10.1073/pnas.0906554106 [eCite] [Details]

Citations: Scopus - 20Web of Science - 19

Tweet

2009Wang Y, Chaudhri G, Jackson RJ, Karupiah G, 'IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection', Journal of Immunology, 183, (5) pp. 3324-3331. ISSN 0022-1767 (2009) [Refereed Article]

DOI: 10.4049/jimmunol.0803985 [eCite] [Details]

Citations: Scopus - 43Web of Science - 40

Tweet

2007Karupiah G, Chaudhri G, 'Immunopathogenesis of infectious disease: injury and death from friendly fire', 85, (1) ISSN 0818-9641 (2007) [Edited Journal]

DOI: 10.1038/sj.icb.7100016 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Tweet

2007Sakala IG, Chaudhri G, Buller RM, Nuara AA, Bai H, et al., 'Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection', Journal of Virology, 81, (7) pp. 3346-3353. ISSN 0022-538X (2007) [Refereed Article]

DOI: 10.1128/JVI.01927-06 [eCite] [Details]

Citations: Scopus - 30Web of Science - 30

Tweet

2006Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G, 'Obligatory requirement for antibody in recovery from a primary poxvirus infection', Journal of Virology, 80, (13) pp. 6339-6344. ISSN 0022-538X (2006) [Refereed Article]

DOI: 10.1128/JVI.00116-06 [eCite] [Details]

Citations: Scopus - 79Web of Science - 74

Tweet

2006Jayasekera JP, Vinuesa GG, Karupiah G, King NJC, 'Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice', Journal of General Virology, 87, (Pt11) pp. 3361-3371. ISSN 0022-1317 (2006) [Refereed Article]

DOI: 10.1099/vir.0.82131-0 [eCite] [Details]

Citations: Scopus - 31Web of Science - 28

Tweet

2006Panchanathan V, Chaudhri G, Karupiah G, 'Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function', Journal of Virology, 80, (13) pp. 6333-8. ISSN 0022-538X (2006) [Refereed Article]

DOI: 10.1128/JVI.00115-06 [eCite] [Details]

Citations: Scopus - 89Web of Science - 85

Tweet

2006Tscharke DC, Woo W-P, Sakala IG, Sidney J, Sette A, et al., 'Poxvirus CD8+ T-Cell determinants and cross-reactivity in BALB/c mice', Journal of Virology, 80, (13) pp. 6318-6323. ISSN 0022-538X (2006) [Refereed Article]

DOI: 10.1128/JVI.00427-06 [eCite] [Details]

Citations: Scopus - 91Web of Science - 87

Tweet

2005Panchanathan V, Chaudhri G, Karupiah G, 'Interferon function is not required for recovery from a secondary poxvirus infection', Proceedings of the National Academy of Sciences, 102, (36) pp. 12921-6. ISSN 0027-8424 (2005) [Refereed Article]

DOI: 10.1073/pnas.0505180102 [eCite] [Details]

Citations: Scopus - 45Web of Science - 42

Tweet

2005Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, et al., 'Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines', The Journal of Experimental Medicine, 201, (1) pp. 95-104. ISSN 0022-1007 (2005) [Refereed Article]

DOI: 10.1084/jem.20041912 [eCite] [Details]

Citations: Scopus - 242Web of Science - 238

Tweet

2004Belz GT, Smith CM, Eichner D, Shortman K, Karupiah G, et al., 'Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses', Journal of Immunology, 172, (4) pp. 1996-2000. ISSN 0022-1767 (2004) [Refereed Article]

DOI: 10.4049/jimmunol.172.4.1996 [eCite] [Details]

Citations: Scopus - 255Web of Science - 241

Tweet

2004Chaudhri G, Panchanathan V, Buller RML, van den Eertwegh AJM, Claassen E, et al., 'Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox', Proceedings of the National Academy of Sciences, 101, (24) pp. 9057-62. ISSN 0027-8424 (2004) [Refereed Article]

DOI: 10.1073/pnas.0402949101 [eCite] [Details]

Citations: Scopus - 92Web of Science - 90

Tweet

2004Kunzelmann K, Konig J, Sun J, Markovich D, King NJ, et al., 'Acute effects of parainfluenza virus on epithelial electrolyte transport', Journal of Biological Chemistry, 279, (47) pp. 48760 -48766. ISSN 0021-9258 (2004) [Refereed Article]

DOI: 10.1074/jbc.M409747200 [eCite] [Details]

Citations: Scopus - 33Web of Science - 33

Tweet

2001Foxwell AR, Kyd JM, Karupiah G, Cripps AW, 'CD8+ T cells have an essential role in pulmonary clearance of nontypeable Haemophilus influenzae following mucosal immunization', Infection and Immunity, 69, (4) pp. 2636-42. ISSN 0019-9567 (2001) [Refereed Article]

DOI: 10.1128/IAI.69.4.2636-2642.2001 [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Tweet

2001Mahalingam S, Chaudhri G, Tan CL, John A, Foster PS, et al., 'Transcription of the interferon gamma (IFN-gamma )-inducible chemokine Mig in IFN-gamma-deficient mice', Journal of Biological Chemistry, 276, (10) pp. 7568-7574. ISSN 0021-9258 (2001) [Refereed Article]

DOI: 10.1074/jbc.M005773200 [eCite] [Details]

Citations: Scopus - 30Web of Science - 31

Tweet

2001Mahalingam S, Karupiah G, Takeda K, Akira S, Matthaei KI, et al., 'Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus', National Academy of Sciences of The United States of America. Proceedings, 98, (12) pp. 6812-6817. ISSN 0027-8424 (2001) [Refereed Article]

DOI: 10.1073/pnas.111151098 [eCite] [Details]

Citations: Scopus - 24Web of Science - 22

Tweet

2000Kunzelmann K, Beesley A, King N, Karupiah G, Young J, et al., 'Unexpected effects of pathogens on epithelial Na+ channels', Journal of Korean Medical Science, 15 pp. S59-60. ISSN 1011-8934 (2000) [Refereed Article]

DOI: 10.3346/jkms.2000.15.S.S59 [eCite] [Details]

Tweet

2000Kunzelmann K, Beesley AH, King NJ, Karupiah G, Young JA, et al., 'Influenza virus inhibits amiloride-sensitive Na1 channels in respiratory epithelia', National Academy of Sciences of The United States of America. Proceedings, 97, (18) pp. 10282-10287. ISSN 0027-8424 (2000) [Refereed Article]

DOI: 10.1073/pnas.160041997 [eCite] [Details]

Citations: Scopus - 108Web of Science - 98

Tweet

2000Mahalingam S, Karupiah G, 'Expression of the interferon-inducible chemokines MuMig and Crg-2 following vaccinia virus infection in vivo', Immunology and Cell Biology, 78, (2) pp. 156-160. ISSN 0818-9641 (2000) [Professional, Refereed Article]

DOI: 10.1046/j.1440-1711.2000.00894.x [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2000Scalzo AA, Farrell HE, Karupiah G, 'Techniques for studying murine natural killer cells in defense against viral infection', Methods in Molecular Biology, 121 pp. 163-77. ISSN 1064-3745 (2000) [Professional, Refereed Article]

DOI: 10.1385/1-59259-044-6:163 [eCite] [Details]

Citations: Scopus - 12

Tweet

1999Mahalingam S, Farber JM, Karupiah G, 'The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo', Journal of Virology, 73, (2) pp. 1479-1491. ISSN 1098-5514 (1999) [Refereed Article]

DOI: 10.1128/JVI.73.2.1479-1491.1999 [eCite] [Details]

Citations: Web of Science - 92

Tweet

1999Simeonovic CJ, Townsend MJ, Karupiah G, Wilson JD, Zarb JC, et al., 'Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response', Cell Transplantation, 8, (4) pp. 365-73. ISSN 0963-6897 (1999) [Refereed Article]

DOI: 10.1177/096368979900800404 [eCite] [Details]

Citations: Scopus - 27Web of Science - 30

Tweet

1999Xiong Y, Karupiah G, Hogan SP, Foster PS, Ramsay AJ, 'Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2', Journal of Immunology, 162, (1) pp. 445-452. ISSN 0022-1767 (1999) [Refereed Article]

PMID: 9886418 [eCite] [Details]

Citations: Web of Science - 119

Tweet

1998Karupiah G, Chen J-H, Mahalingam S, Nathan CF, MacMicking JD, 'Rapid Interferon g-dependent Clearance of Influenza A Virus and Protection from Consolidating Pneumonitis in Nitric Oxide Synthase 2-deficient Mice', The Journal of Experimental Medicine, 188, (8) pp. 1541-1546. ISSN 0022-1007 (1998) [Refereed Article]

DOI: 10.1084/jem.188.8.1541 [eCite] [Details]

Citations: Scopus - 152Web of Science - 143

Tweet

1998Karupiah G, Chen J-H, Nathan CF, Mahalingam S, MacMicking JD, 'Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection', Journal of Virology, 79, (2) pp. 7703-7706. ISSN 0022-538X (1998) [Refereed Article]

DOI: 10.1128/JVI.72.9.7703-7706.1998 [eCite] [Details]

Citations: Web of Science - 48

Tweet

1998Karupiah G, Sacks TE, Klinman DM, Fredrickson TN, Hartley JW, et al., 'Murine Cytomegalovirus Infection-Induced Polyclonal B Cell Activation Is Independent of CD41 T Cells and CD40', Virology, 240, (1) pp. 12-26. ISSN 0042-6822 (1998) [Refereed Article]

DOI: 10.1006/viro.1997.8900 [eCite] [Details]

Citations: Scopus - 34Web of Science - 32

Tweet

1997Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam RS, et al., 'Cytokines and immunity to viral infections', Immunological Reviews, 159 pp. 119-135. ISSN 0105-2896 (1997) [Refereed Article]

DOI: 10.1111/j.1600-065x.1997.tb01011.x [eCite] [Details]

Citations: Web of Science - 215

Tweet

1996Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, et al., 'Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo', Journal of Immunology, 157, (10) pp. 4511-4520. ISSN 0022-1767 (1996) [Refereed Article]

PMID: 8906829 [eCite] [Details]

Citations: Web of Science - 130

Tweet

1996Karupiah G, Buller RML, Van Rooijen N, Duarte CL, Chen J, 'Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection', Journal of Virology, 70, (12) pp. 8301-8309. ISSN 0022-538X (1996) [Refereed Article]

DOI: 10.1128/JVI.70.12.8301-8309.1996 [eCite] [Details]

Citations: Web of Science - 144

Tweet

1995Harris N, Buller RM, Karupiah G, 'Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication', Journal of Virology, 69, (2) pp. 910-915. ISSN 0022-538X (1995) [Refereed Article]

DOI: 10.1128/JVI.69.2.910-915.1995 [eCite] [Details]

Citations: Web of Science - 144

Tweet

1995Karupiah G, Harris N, 'Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites', The Journal of Experimental Medicine, 181, (6) pp. 2171-2179. ISSN 0022-1007 (1995) [Refereed Article]

DOI: 10.1084/jem.181.6.2171 [eCite] [Details]

Citations: Scopus - 88Web of Science - 90

Tweet

1994Cox JH, Buller RM, Bennink JR, Yewdell JW, Karupiah G, 'Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus', Virology, 204, (2) pp. 558-62. ISSN 0042-6822 (1994) [Refereed Article]

DOI: 10.1006/viro.1994.1569 [eCite] [Details]

Citations: Scopus - 15Web of Science - 16

Tweet

1993Karupiah G, Fredrickson TN, Holmes KL, Khairallah LH, Buller RM, 'Importance of interferons in recovery from mousepox', Journal of Virology, 67, (7) pp. 4214-26. ISSN 0022-538X (1993) [Refereed Article]

DOI: 10.1128/JVI.67.7.4214-4226.1993 [eCite] [Details]

Citations: Scopus - 141Web of Science - 138

Tweet

1993Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, et al., 'Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase', Science, 261, (5127) pp. 1445-8. ISSN 0036-8075 (1993) [Refereed Article]

DOI: 10.1126/science.7690156 [eCite] [Details]

Citations: Scopus - 720Web of Science - 740

Tweet

1992Karupiah G, Ramsay AJ, Ramshaw IA, Blanden RV, 'Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms', Scandinavian Journal of Immunology, 36, (1) pp. 99-105. ISSN 0300-9475 (1992) [Refereed Article]

DOI: 10.1111/j.1365-3083.1992.tb02945.x [eCite] [Details]

Citations: Scopus - 12Web of Science - 13

Tweet

1992Ramshaw I, Ruby J, Ramsay A, Ada G, Karupiah G, 'Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo', Immunological Reviews, 127 pp. 157-182. ISSN 0105-2896 (1992) [Refereed Article]

DOI: 10.1111/j.1600-065x.1992.tb01413.x [eCite] [Details]

Citations: Web of Science - 140

Tweet

1991Andrew ME, Karupiah G, Boyle DB, Blanden RV, Mullbacher A, et al., 'Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice', Microbial Pathogenesis, 10, (5) pp. 363-71. ISSN 0882-4010 (1991) [Refereed Article]

DOI: 10.1016/0882-4010(91)90081-k [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Tweet

1991Karupiah G, Woodhams CE, Blanden RV, Ramshaw IA, 'Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice', Journal of Immunology, 147, (12) pp. 4327-32. ISSN 0022-1767 (1991) [Refereed Article]

PMID: 1684375 [eCite] [Details]

Citations: Web of Science - 28

Tweet

1990Karupiah G, Blanden RV, 'Anti-asialo-GM1 inhibits vaccinia virus infection of murine ovaries: asialo-GM1 as an additional virus receptor?', Immunology and Cell Biology, 68, (Pt 5) pp. 343-6. ISSN 0818-9641 (1990) [Refereed Article]

DOI: 10.1038/icb.1990.46 [eCite] [Details]

Citations: Web of Science - 13

Tweet

1990Karupiah G, Blanden RV, Ramshaw IA, 'Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection', The Journal of Experimental Medicine, 172, (5) pp. 1495-503. ISSN 0022-1007 (1990) [Refereed Article]

DOI: 10.1084/jem.172.5.1495 [eCite] [Details]

Citations: Scopus - 93Web of Science - 114

Tweet

1990Karupiah G, Coupar B, Ramshaw I, Boyle D, Blanden R, et al., 'Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2', Immunology and Cell Biology, 68, (Pt 5) pp. 325-333. ISSN 0818-9641 (1990) [Refereed Article]

DOI: 10.1038/icb.1990.44 [eCite] [Details]

Citations: Web of Science - 32

Tweet

1990Karupiah G, Coupar BE, Andrew ME, Boyle DB, Phillips SM, et al., 'Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2', Journal of Immunology, 144, (1) pp. 290-8. ISSN 0022-1767 (1990) [Refereed Article]

PMID: 2295796 [eCite] [Details]

Citations: Web of Science - 108

Tweet

1988Gunasegaran K, Lam SK, Pang T, 'Modification and improvement of the haemadsorption immunosorbent technique (HIT) for the detection of dengue IgM antibodies', The Malaysian Journal of Pathology, 10 pp. 73-7. ISSN 0126-8635 (1988) [Refereed Article]

PMID: 3252082 [eCite] [Details]

Tweet

Book

(1 outputs)
YearCitationAltmetrics
1997Karupiah G, 'Gamma Interferon in Antiviral Defense', Chapman & Hall, United States, pp. 192. ISBN 0412130416 (1997) [Edited Book]

[eCite] [Details]

Chapter in Book

(4 outputs)
YearCitationAltmetrics
2007Karupiah G, Panchanathan V, Sakala IG, Chaudhri G, 'Genetic resistance to smallpox: lessons from mousepox', Decoding the Genomic Control of Immune Reactions, Wiley, GR Bock and JA Goode (ed), United States, pp. 129-140. ISBN 978-0-470-02755-4 (2007) [Research Book Chapter]

DOI: 10.1002/9780470062128.ch11 [eCite] [Details]

Citations: Scopus - 6

Tweet

1997Ada G, Karupiah G, 'Overview of Host Defense Mechanisms with Special Reference to Viral Infections', Gamma Interferon in Antiviral Defense, Chapman & Hall, G Karupiah (ed), United States, pp. 1-18. ISBN 0412130416 (1997) [Research Book Chapter]

[eCite] [Details]

1997Karupiah G, Harris N, 'Gamma Interferon-Induced Nitric Oxide in Antiviral Defense and Immunopathology', Gamma Interferon in Antiviral Defense, Chapman & Hall, G Karupiah (ed), United States, pp. 119-142. ISBN 0412130416 (1997) [Research Book Chapter]

[eCite] [Details]

1989Ramshaw IA, Sambhi S, Karupiah G, Kohonen-Corish M, Ruby J, et al., 'Vaccinia-Directed Cytokine Gene Expression and Infection', Immunology of Virus Diseases, John Curtin School of Medical Research, RV Blanden (ed), Australia, pp. 35-46. ISBN 0958830991 (1989) [Research Book Chapter]

[eCite] [Details]

Review

(8 outputs)
YearCitationAltmetrics
2021Pandey P, Karupiah G, 'Targeting tumour necrosis factor to ameliorate viral pneumonia', The FEBS Journal pp. 1-18. ISSN 1742-464X (2021) [Substantial Review]

DOI: 10.1111/febs.15782 [eCite] [Details]

Co-authors: Pandey P

Tweet

2008Panchanathan V, Chaudhri G, Karupiah G, 'Correlates of protective immunity in poxvirus infection: where does antibody stand?', Immunology and Cell Biology, 86, (1) pp. 80-6. ISSN 0818-9641 (2008) [Substantial Review]

DOI: 10.1038/sj.icb.7100118 [eCite] [Details]

Citations: Scopus - 65Web of Science - 58

Tweet

2007Stanford MM, McFadden G, Karupiah G, Chaudhri G, 'Immunopathogenesis of poxvirus infections: forecasting the impending storm', Immunology and Cell Biology, 85, (2) pp. 93-102. ISSN 0818-9641 (2007) [Substantial Review]

DOI: 10.1038/sj.icb.7100033 [eCite] [Details]

Citations: Scopus - 61Web of Science - 59

Tweet

2000Karupiah G, Hunt NH, King NJ, Chaudhri G, 'NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response', Reviews In Immunogenetics, 2, (3) pp. 387-415. ISSN 1398-1714 (2000) [Substantial Review]

PMID: 11256747 [eCite] [Details]

Tweet

2000Mahalingam S, Foster PS, Lobigs M, Farber JM, Karupiah G, 'Interferon-inducible chemokines and immunity to poxvirus infections', Immunological Reviews, 177 pp. 127-33. ISSN 0105-2896 (2000) [Substantial Review]

DOI: 10.1034/j.1600-065x.2000.17720.x [eCite] [Details]

Citations: Web of Science - 20

Tweet

2000Mahalingam S, Karupiah G, 'Modulation of chemokines by poxvirus infections', Current Opinion in Immunology, 12, (4) pp. 409-12. ISSN 0952-7915 (2000) [Substantial Review]

DOI: 10.1016/s0952-7915(00)00109-6 [eCite] [Details]

Citations: Scopus - 26Web of Science - 26

Tweet

1999Mahalingam S, Karupiah G, 'Chemokines and chemokine receptors in infectious diseases', Immunology and Cell Biology, 77, (6) pp. 469-75. ISSN 0818-9641 (1999) [Substantial Review]

DOI: 10.1046/j.1440-1711.1999.00858.x [eCite] [Details]

Citations: Scopus - 94Web of Science - 88

Tweet

1998Karupiah G, 'Type 1 and type 2 cytokines in antiviral defense', Veterinary Immunology and Immunopathology, 63, (1-2) pp. 105-9. ISSN 0165-2427 (1998) [Substantial Review]

DOI: 10.1016/s0165-2427(98)00086-5 [eCite] [Details]

Citations: Scopus - 55Web of Science - 53

Tweet

Grants & Funding

Guna Karupiah has held prestigious fellowships such as the Fogarty Fellowship (National Institutes of Health (NIH, USA)); the Medical Foundation Fellowship (University of Sydney); and International Research Scholar of the Howard Hughes Medical Institute (HHMI, USA), and has been successful in obtaining national and international competitive research grants. Since 1999, he has obtained individual and collaborative grants totalling over $10 million.

Funding Summary

Number of grants

19

Total funding

$89,630,225

Projects

ICG - GREYSCAN PTY LTD (2020)$259,020
Description
With GreyScan will repurpose the ETD-100 trace explosives system to detect viruses and create a new product range, TVD 1
Funding
GreyScan Pty Ltd ($259,020)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Breadmore MC; King AE; Karupiah G; Flies AS; Wilson CR; Flies E; Gell DA
Year
2020
Novel combination therapy for effective virus control and amelioration of influenza pneumonia (2019)$23,875
Description
There is currently no treatment available for viral pneumonia. We have developed a novel combination therapy for effective control and amelioration of influenza pneumonia. The drugs we use are currently used in humans, however not for the purpose described in the application. We do not yet know the mechanisms through which the combination treatment affords protection, and if the drugs can be administered through the respiratory route to treat influenza pneumonia effectively.We do not yet know the mechanisms through which the combination treatment affords protection, and whether the drugs can be administered through the respiratory route to treat influenza pneumonia effectively. These questions form the basis of the application. An understanding of both the mechanism(s) through which the treatment works, as well as determining an effective and practical route of delivery, will result in targeted, efficacious, and feasible clinical solutions to treatment of influenza pneumonia.
Funding
The MPST Foundation Ltd ($23,875)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Karupiah G
Year
2019
Systems Approach to Immunity and Inflammation (2012 - 2016)$31,000,000
Funding
National Institutes of Health (NIH), USA ($31,000,000)
Scheme
U19 Program grant (NIH U19 RFA-AI-017)
Administered By
Australian National University (ANU), The Scripps Research Institute (TSRI), Seattle Biomed (SB), University of Texas Southwestern (UTSW), Stanford University (SU)
Research Team
Ulevitch R; Goodnow C; Karupiah G; Aderem A; Beutler B; Nolan G
Period
2012 - 2016
Regulation of leukocyte migration and interaction by the homing receptor EBI2 (2011 - 2013)$493,654
Funding
National Health and Medical Research Council ($493,654)
Scheme
Project grant (APP1003025)
Administered By
Garvan Institute for Medical Research (Garvan) and Australian National University (ANU)
Research Team
Gatto D; Pha T; Karupiah G
Period
2011 - 2013
Understanding the key attributes of CD8 T cell receptor transfer as an antiviral strategy and harnessing the process to combat persistent viral infections (2011 - 2013)$591,732
Funding
National Health and Medical Research Council ($591,732)
Scheme
Project grant (APP1007980)
Administered By
Australian National University (ANU)
Research Team
Karupiah G; Chaudhri G
Period
2011 - 2013
Antiviral targeting of motility (2010 - 2012)$318,817
Funding
National Health and Medical Research Council ($318,817)
Scheme
Project Grant
Administered By
University of Sydney (USyd); Australian National University (ANU)
Research Team
Newsome T; Karupiah G
Period
2010 - 2012
A novel strategy to regulate host antiviral immune response and inflammation through mTNF (2008 - 2010)$568,501
Funding
National Health and Medical Research Council ($568,501)
Scheme
Project Grant
Administered By
Australian National University (ANU)
Research Team
Chaudhri G; Karupiah G
Period
2008 - 2010
Systems Approach to Immunity and Inflammation (2007 - 2011)$51,000,000
Funding
National Institutes of Health (NIH), USA ($51,000,000)
Scheme
NIH Program grant (HHSN272200700038C)
Administered By
Australian National University (ANU), The Scripps Research Institute (TSRI), Seattle Biomed (SB), University of Texas Southwestern (UTSW), Stanford University (SU)
Research Team
Ulevitch R; Goodnow C; Karupiah G; Aderem A; Beutler B; Nolan G
Period
2007 - 2011
Immunity to viral infections (2007 - 2011)$616,452
Funding
National Health and Medical Research Council ($616,452)
Scheme
NHMRC Fellowship (SRF B)
Administered By
Australian National University (ANU)
Research Team
Karupiah G
Period
2007 - 2011
CD8+ T cell responses in mouse models of smallpox vaccination and challenge (2007 - 2009)$968,000
Funding
National Institutes of Health (NIH), USA ($968,000)
Scheme
NIH RO1 grant
Administered By
Australian National University (ANU); University of Washington in St Louis (WU)
Research Team
Tscharke D; Karupiah G; Buller M
Period
2007 - 2009
Immunity to viral infections (2007 - 2011)$558,000
Funding
National Health and Medical Research Council ($558,000)
Scheme
NHMRC Fellowship (SRF B) (GNT0179830)
Administered By
Australian National University (ANU)
Research Team
Karupiah G
Period
2007 - 2011
Role of plasmacytoid dendritic cells and neutrophils in the generation of antiviral immunity (2005 - 2007)$469,500
Funding
National Health and Medical Research Council ($469,500)
Scheme
Project grant
Administered By
Australian National University
Research Team
Karupiah G
Period
2005 - 2007
Critical role of TNF in host-virus interactions and outcome of infection: Involvement of reverse signalling through mTNF (2004 - 2006)$496,500
Funding
National Health and Medical Research Council ($496,500)
Scheme
Project grant (GNT0268037)
Administered By
Australian National University (ANU)
Research Team
Chaudhri G; Karupiah G
Period
2004 - 2006
Critical soluble effector molecules causing immune damage in a model of West Nile virus encephalitis (2003 - 2005)$250,500
Funding
National Health and Medical Research Council ($250,500)
Scheme
Project grant (GNT0253771)
Administered By
Australian National University (ANU); University of Sydney (USyd)
Research Team
King N; Karupiah G; Kesson A; Chaudhri G
Period
2003 - 2005
Pathophysiological significance of reverse signalling through membrane TNF (2001 - 2003)$453,055
Funding
National Health and Medical Research Council ($453,055)
Scheme
Project grant (GNT0153835)
Administered By
Australian National University (ANU)
Research Team
Chaudhri G; KArupiah G
Period
2001 - 2003
Control of influenza A virus infection by gamma interferon-inducible mediators (2001 - 2003)$227,036
Funding
National Health and Medical Research Council ($227,036)
Scheme
Project grant (GNT0153836)
Administered By
Australian National University (ANU)
Research Team
Karupiah G
Period
2001 - 2003
Immunity to viral infections (2000 - 2004)$450,000
Funding
The Howard Hughes Medical Institute (USA) ($450,000)
Scheme
International Research Fellowship
Administered By
Australian National University (ANU)
Research Team
Karupiah G
Period
2000 - 2004
Role of nitric oxide in influenza A virus-induced pneumonia (1999 - 2001)$390,583
Funding
National Health and Medical Research Council ($390,583)
Scheme
Project grant (GNT0990583)
Administered By
University of Sydney (USyd)
Research Team
Karupiah G; King N
Period
1999 - 2001
Models of human viral disease: Role of nitric oxide and chemokines in the pathogenesis of lethal pneumonia and encephalitis as a basis for interventive drug development (1999 - 2001)$495,000
Funding
University of Sydney Medical Foundation ($495,000)
Scheme
Fellowship
Administered By
University of Sydney (USyd)
Research Team
Karupiah G; King N
Period
1999 - 2001

Research Supervision

Guna is involved in a diverse range of teaching activities. He has extensive tertiary teaching experience in the forms of supervision of Honours, Higher Degree Research and postgraduate medical research students, undergraduate lecturing and research supervision, and international postdoctoral and postgraduate training. Since 1998, he has trained 2 Research Fellows, 5 Postdoctoral Fellows, 15 PhD students and 11 Honours students. In recognition of his contribution to teaching, training and mentoring students, he was recognised as a Senior Fellow of the Higher Education Academy, United Kingdom (2014).

He has a number of exciting Honours and PhD projects (see Current Research Projects).

Current

1

Completed

1

Current

DegreeTitleCommenced
PhDNovel Approaches to Treat Viral Pneumonia2017

Completed

DegreeTitleCompleted
PhDExploring Molecular Mechanisms Underlying the Role of Non-typeable Haemophilus influenzae in COPD
Candidate: Rajendra KC
2020